Sanofi has completed the $3.2 billion acquisition of US biotech Translate Bio after the tender offer for all shares expired as scheduled at midnight US Eastern Daylight...

French drugmaker Sanofi may reconsider plans to acquire Translate Bio at the conditions recently announced, the US biotech said in a filing with the US Securities and...

French drugmaker Sanofi has signed a definitive agreement to acquire Translate Bio, the clinical-stage mRNA therapeutics company with which it is currently cooperating on...

Sanofi Pasteur, the vaccines global business unit of French drugmaker Sanofi, and Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, are formally...